Literature DB >> 22546915

A new apparatus and surgical technique for the dual perfusion of human tumor xenografts in situ in nude rats.

Robert T Dauchy1, Erin M Dauchy, Lulu Mao, Victoria P Belancio, Steven M Hill, David E Blask.   

Abstract

We present a new perfusion system and surgical technique for simultaneous perfusion of 2 tissue-isolated human cancer xenografts in nude rats by using donor blood that preserves a continuous flow. Adult, athymic nude rats (Hsd:RH-Foxn1(rnu)) were implanted with HeLa human cervical or HT29 colon adenocarcinomas and grown as tissue-isolated xenografts. When tumors reached an estimated weight of 5 to 6 g, rats were prepared for perfusion with donor blood and arteriovenous measurements. The surgical procedure required approximately 20 min to complete for each tumor, and tumors were perfused for a period of 150 min. Results showed that tumor venous blood flow, glucose uptake, lactic acid release, O(2) uptake and CO(2) production, uptake of total fatty acid and linoleic acid and conversion to the mitogen 13-HODE, cAMP levels, and activation of several marker kinases were all well within the normal physiologic, metabolic, and signaling parameters characteristic of individually perfused xenografts. This new perfusion system and technique reduced procedure time by more than 50%. These findings demonstrate that 2 human tumors can be perfused simultaneously in situ or ex vivo by using either rodent or human blood and suggest that the system may also be adapted for use in the dual perfusion of other organs. Advantages of this dual perfusion technique include decreased anesthesia time, decreased surgical manipulation, and increased efficiency, thereby potentially reducing the numbers of laboratory animals required for scientific investigations.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22546915      PMCID: PMC3318246     

Source DB:  PubMed          Journal:  Comp Med        ISSN: 1532-0820            Impact factor:   0.982


  34 in total

Review 1.  Coordination of circadian timing in mammals.

Authors:  Steven M Reppert; David R Weaver
Journal:  Nature       Date:  2002-08-29       Impact factor: 49.962

2.  Mass-dependent decline of skeletal muscle function in cancer cachexia.

Authors:  Marchel Gorselink; Stefan F C Vaessen; Laurens G van der Flier; Inge Leenders; Diane Kegler; Eric Caldenhoven; Eline van der Beek; Ardy van Helvoort
Journal:  Muscle Nerve       Date:  2006-05       Impact factor: 3.217

3.  Melatonin-depleted blood from premenopausal women exposed to light at night stimulates growth of human breast cancer xenografts in nude rats.

Authors:  David E Blask; George C Brainard; Robert T Dauchy; John P Hanifin; Leslie K Davidson; Jean A Krause; Leonard A Sauer; Moises A Rivera-Bermudez; Margarita L Dubocovich; Samar A Jasser; Darin T Lynch; Mark D Rollag; Frederick Zalatan
Journal:  Cancer Res       Date:  2005-12-01       Impact factor: 12.701

4.  Human cancer xenograft perfusion in situ in rats: a new perfusion system that minimizes delivery time and maintains normal tissue physiology and responsiveness to growth-inhibitory agents.

Authors:  Erin M Dauchy; Robert T Dauchy; Leslie K Davidson; Darin T Lynch; Jean A Krause; Lia M Blue; Leonard A Sauer; David E Blask
Journal:  J Am Assoc Lab Anim Sci       Date:  2006-05       Impact factor: 1.232

5.  Melatonin inhibition of cancer growth in vivo involves suppression of tumor fatty acid metabolism via melatonin receptor-mediated signal transduction events.

Authors:  D E Blask; L A Sauer; R T Dauchy; E W Holowachuk; M S Ruhoff; H S Kopff
Journal:  Cancer Res       Date:  1999-09-15       Impact factor: 12.701

6.  Preparation of the inguinal fat pad for perfusion in situ in the rat: a surgical technique that preserves continuous blood flow.

Authors:  R T Dauchy; D E Blask; L A Sauer
Journal:  Contemp Top Lab Anim Sci       Date:  2000-09

7.  Inhibition of fatty acid transport and proliferative activity in tissue-isolated human squamous cell cancer xenografts perfused in situ with melatonin or eicosapentaenoic or conjugated linoleic acids.

Authors:  Robert T Dauchy; Erin M Dauchy; Leslie K Davidson; Jean A Krause; Darin T Lynch; Paul C Tirrell; Robert P Tirrell; Leonard A Sauer; Peter Van der Riet; David E Blask
Journal:  Comp Med       Date:  2007-08       Impact factor: 0.982

8.  The effect of vasoconstrictors on oxygen consumption in resting and contracting skeletal muscle of the autologous pump-perfused rat hindlimb.

Authors:  A J Hoy; G E Peoples; P L McLennan
Journal:  J Physiol Pharmacol       Date:  2009-09       Impact factor: 3.011

9.  Antineoplastic effects of melatonin on a rare malignancy of mesenchymal origin: melatonin receptor-mediated inhibition of signal transduction, linoleic acid metabolism and growth in tissue-isolated human leiomyosarcoma xenografts.

Authors:  Robert T Dauchy; David E Blask; Erin M Dauchy; Leslie K Davidson; Paul C Tirrell; Michael W Greene; Robert P Tirrell; Cody R Hill; Leonard A Sauer
Journal:  J Pineal Res       Date:  2009-05-27       Impact factor: 13.007

10.  The isolated perfused rat kidney model: a useful tool for drug discovery and development.

Authors:  David R Taft
Journal:  Curr Drug Discov Technol       Date:  2004-01
View more
  4 in total

1.  Effect of Daytime Blue-enriched LED Light on the Nighttime Circadian Melatonin Inhibition of Hepatoma 7288CTC Warburg Effect and Progression.

Authors:  Robert T Dauchy; Melissa A Wren-Dail; Lynell M Dupepe; Steven M Hill; Shulin Xiang; Muralidharan Anbalagan; Victoria P Belancio; Erin M Dauchy; David E Blask
Journal:  Comp Med       Date:  2018-06-06       Impact factor: 0.982

2.  Daytime Blue Light Enhances the Nighttime Circadian Melatonin Inhibition of Human Prostate Cancer Growth.

Authors:  Robert T Dauchy; Aaron E Hoffman; Melissa A Wren-Dail; John P Hanifin; Benjamin Warfield; George C Brainard; Shulin Xiang; Lin Yuan; Steven M Hill; Victoria P Belancio; Erin M Dauchy; Kara Smith; David E Blask
Journal:  Comp Med       Date:  2015-12       Impact factor: 0.982

3.  Regulation of L1 expression and retrotransposition by melatonin and its receptor: implications for cancer risk associated with light exposure at night.

Authors:  Dawn deHaro; Kristine J Kines; Mark Sokolowski; Robert T Dauchy; Vincent A Streva; Steven M Hill; John P Hanifin; George C Brainard; David E Blask; Victoria P Belancio
Journal:  Nucleic Acids Res       Date:  2014-06-09       Impact factor: 16.971

4.  The endonuclease domain of the LINE-1 ORF2 protein can tolerate multiple mutations.

Authors:  Kristine J Kines; Mark Sokolowski; Dawn L deHaro; Claiborne M Christian; Melody Baddoo; Madison E Smither; Victoria P Belancio
Journal:  Mob DNA       Date:  2016-04-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.